Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Loss of maternal annexin A5 increases the likelihood of placental platelet thrombosis and foetal loss.

Ueki H, Mizushina T, Laoharatchatathanin T, Terashima R, Nishimura Y, Rieanrakwong D, Yonezawa T, Kurusu S, Hasegawa Y, Brachvogel B, Pöschl E, Kawaminami M.

Sci Rep. 2012;2:827. doi: 10.1038/srep00827. Epub 2012 Nov 9.

2.

Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction.

Sifakis S, Soufla G, Koukoura O, Soulitzis N, Koutroulakis D, Maiz N, Konstantinidou A, Melissari E, Spandidos DA.

Thromb Res. 2010 Apr;125(4):326-31. doi: 10.1016/j.thromres.2009.11.033. Epub 2009 Dec 24.

PMID:
20034656
3.
4.

Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia.

Ota S, Miyamura H, Nishizawa H, Inagaki H, Inagaki A, Inuzuka H, Suzuki M, Miyazaki J, Sekiya T, Udagawa Y, Kurahashi H.

Placenta. 2013 Dec;34(12):1202-10. doi: 10.1016/j.placenta.2013.09.010. Epub 2013 Oct 7.

PMID:
24140079
5.

The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.

Rand JH, Wu XX, Quinn AS, Taatjes DJ.

Lupus. 2010 Apr;19(4):460-9. doi: 10.1177/0961203310361485. Review.

PMID:
20353989
6.

Independent association of the M2/ANXA5 haplotype with recurrent pregnancy loss (RPL) in PCOS patients.

Rogenhofer N, Engels L, Bogdanova N, Tüttelmann F, Thaler CJ, Markoff A.

Metabolism. 2013 Aug;62(8):1057-60. doi: 10.1016/j.metabol.2013.02.005. Epub 2013 Mar 15.

PMID:
23498654
7.

Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.

de Laat B, Derksen RH, Mackie IJ, Roest M, Schoormans S, Woodhams BJ, de Groot PG, van Heerde WL.

Ann Rheum Dis. 2006 Nov;65(11):1468-72. Epub 2006 Jan 31.

8.

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.

Rand JH, Wu XX, Quinn AS, Ashton AW, Chen PP, Hathcock JJ, Andree HA, Taatjes DJ.

Blood. 2010 Mar 18;115(11):2292-9. doi: 10.1182/blood-2009-04-213520. Epub 2009 Nov 30.

9.

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.

Rand JH, Wu XX, Guller S, Gil J, Guha A, Scher J, Lockwood CJ.

Am J Obstet Gynecol. 1994 Dec;171(6):1566-72.

PMID:
7802069
10.

Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.

Rand JH, Wu XX, Guller S, Scher J, Andree HA, Lockwood CJ.

Am J Obstet Gynecol. 1997 Oct;177(4):918-23.

PMID:
9369845
11.

[Annexins and recurrent pregnancy loss].

Udry S, Aranda F, Latino O, Larrañaga Gd.

Medicina (B Aires). 2013;73(5):495-500. Review. Spanish.

12.

Annexin V is critical in the maintenance of murine placental integrity.

Wang X, Campos B, Kaetzel MA, Dedman JR.

Am J Obstet Gynecol. 1999 Apr;180(4):1008-16.

PMID:
10203671
13.

Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele.

Markoff A, Gerdes S, Feldner S, Bogdanova N, Gerke V, Grandone E.

Placenta. 2010 Oct;31(10):937-40. doi: 10.1016/j.placenta.2010.08.002.

PMID:
20805002
14.

Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.

de Laat B, Wu XX, van Lummel M, Derksen RH, de Groot PG, Rand JH.

Blood. 2007 Feb 15;109(4):1490-4. Epub 2006 Oct 19.

15.

Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.

Rand JH, Wu XX, Quinn AS, Taatjes DJ.

Lupus. 2008 Oct;17(10):922-30. doi: 10.1177/0961203308095029. Review.

PMID:
18827057
16.

Reduced ANXA5 mRNA and protein expression in pregnancies complicated by preeclampsia.

Gourvas V, Soulitzis N, Konstantinidou A, Dalpa E, Koukoura O, Koutroulakis D, Spandidos DA, Sifakis S.

Thromb Res. 2014 Mar;133(3):495-500. doi: 10.1016/j.thromres.2013.12.027. Epub 2013 Dec 22.

PMID:
24393658
17.

Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk.

Tüttelmann F, Ivanov P, Dietzel C, Sofroniou A, Tsvyatkovska TM, Komsa-Penkova RS, Markoff A, Wieacker P, Bogdanova N.

Fertil Steril. 2013 Nov;100(5):1321-5. doi: 10.1016/j.fertnstert.2013.06.046. Epub 2013 Jul 27.

PMID:
23899942
18.

Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome.

Hunt BJ, Wu XX, de Laat B, Arslan AA, Stuart-Smith S, Rand JH.

Am J Obstet Gynecol. 2011 Nov;205(5):485.e17-23. doi: 10.1016/j.ajog.2011.06.019. Epub 2011 Jun 15.

19.

Antibodies against annexin A5: detection pitfalls and clinical associations.

Bozic B, Irman S, Gaspersic N, Kveder T, Rozman B.

Autoimmunity. 2005 Sep;38(6):425-30. Review.

PMID:
16278147
20.

Anti-annexin A5 antibodies in women with spontaneous pregnancy loss.

Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ, Farran-Codina I, Llurba-Olivé E, Vilardell-Tarres M, Casellas-Caro M.

Med Clin (Barc). 2010 Apr 10;134(10):433-8. doi: 10.1016/j.medcli.2009.09.040. Epub 2009 Dec 22.

PMID:
20022614

Supplemental Content

Support Center